Procyon Advisors, LLC Astrazeneca PLC Transaction History

Procyon Advisors, LLC

$1.54 Billion
Q4 2024

A detailed history of Procyon Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Procyon Advisors, LLC holds 33,695 shares of AZN stock, worth $2.55 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

33,695

Previous 29,853 12.87%

Holding current value

$2.55 Million

Previous $2.33 Million 5.12%

% of portfolio

0.14%

Previous 0.16%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 15, 2025	BUY	$63.2 - $79.58 $242,814 - $305,746	3,842 Added 12.87%	33,695 $2.21 Million
Q3 2024 Oct 11, 2024	BUY	$76.67 - $87.62 $250,710 - $286,517	3,270 Added 12.3%	29,853 $2.33 Million
Q2 2024 Aug 02, 2024	BUY	$66.81 - $80.83 $135,824 - $164,327	2,033 Added 8.28%	26,583 $2.07 Million
Q1 2024 Apr 15, 2024	BUY	$61.03 - $69.57 $209,821 - $239,181	3,438 Added 16.28%	24,550 $1.66 Million
Q4 2023 Jan 18, 2024	BUY	$61.89 - $69.28 $988,383 - $1.11 Million	15,970 Added 310.58%	21,112 $1.42 Million
Q3 2023 Oct 10, 2023	BUY	$64.85 - $71.7 $90,400 - $99,949	1,394 Added 37.19%	5,142 $348,000
Q2 2023 Jul 17, 2023	BUY	$69.91 - $75.81 $1,677 - $1,819	24 Added 0.64%	3,748 $268,000
Q1 2023 Apr 10, 2023	SELL	$63.15 - $71.6 $37,574 - $42,602	-595 Reduced 13.78%	3,724 $258,000
Q4 2022 Jan 19, 2023	BUY	$54.21 - $70.44 $5,041 - $6,550	93 Added 2.2%	4,319 $0
Q3 2022 Oct 17, 2022	SELL	$53.02 - $135.75 $1,219 - $3,122	-23 Reduced 0.54%	4,226 $232,000
Q2 2022 Jul 11, 2022	SELL	$59.26 - $71.14 $10,074 - $12,093	-170 Reduced 3.85%	4,249 $281,000
Q1 2022 Apr 18, 2022	SELL	$55.72 - $67.12 $47,529 - $57,253	-853 Reduced 16.18%	4,419 $293,000
Q4 2021 Jan 18, 2022	BUY	$54.02 - $63.83 $21,932 - $25,914	406 Added 8.34%	5,272 $307,000
Q3 2021 Oct 14, 2021	SELL	$55.56 - $60.79 $4,000 - $4,376	-72 Reduced 1.46%	4,866 $292,000
Q2 2021 Jul 22, 2021	BUY	$48.42 - $60.18 $5,326 - $6,619	110 Added 2.28%	4,938 $296,000
Q4 2020 Jan 19, 2021	BUY	$48.52 - $58.02 $11,693 - $13,982	241 Added 5.25%	4,828 $241,000
Q3 2020 Oct 22, 2020	SELL	$53.07 - $61.1 $67,292 - $77,474	-1,268 Reduced 21.66%	4,587 $251,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $10,430 - $13,385	-242 Reduced 3.97%	5,855 $310,000
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $3,779 - $5,133	-100 Reduced 1.61%	6,097 $272,000
Q4 2019 Feb 21, 2020	BUY	$42.46 - $50.46 $263,124 - $312,700	6,197 New	6,197 $309,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $234B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Procyon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Procyon Advisors, LLC with notifications on news.

Account

Procyon Advisors, LLC Astrazeneca PLC Transaction History